NMT share price plunges as cardiac implant for migraine trial disappoints
This article was originally published in Clinica
Executive Summary
Shares in NMT Medical plummeted this week after a widely- anticipated study failed to prove that its catheter-based implant for closing a hole in the heart could prevent migraine headaches, writes Neena Brizmohun at the American College of Cardiology meeting, in Atlanta.